Clinical significance of radiation-induced CD133 expression in residual rectal cancer cells after chemoradiotherapy (Q36224182)

12 August 2017

Clinical significance of radiation-induced CD133 expression in residual rectal cancer cells after chemoradiotherapy (English)

1 reference

12 August 2017

0 references

Aya Kawamoto

1

1 reference

12 August 2017

Koji Tanaka

2

1 reference

12 August 2017

Susumu Saigusa

3

1 reference

12 August 2017

Yuji Toiyama

4

1 reference

12 August 2017

Yuhki Morimoto

5

1 reference

12 August 2017

Hiroyuki Fujikawa

6

1 reference

12 August 2017

Takashi Iwata

7

1 reference

12 August 2017

Kohei Matsushita

8

1 reference

12 August 2017

Takeshi Yokoe

9

1 reference

12 August 2017

Hiromi Yasuda

10

1 reference

12 August 2017

Yasuhiro Inoue

11

1 reference

12 August 2017

Chikao Miki

12

1 reference

12 August 2017

Masato Kusunoki

13

1 reference

12 August 2017

28 December 2011

1 reference

Experimental and Therapeutic Medicine

12 August 2017

1 reference

12 August 2017

3

1 reference

12 August 2017

3

1 reference

12 August 2017

403-409

1 reference

Characterization of a subpopulation of colon cancer cells with stem cell-like properties

12 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3438555

CD133 expression is an independent prognostic marker for low survival in colorectal cancer

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3438555

Survival of the fittest: cancer stem cells in therapeutic resistance and angiogenesis

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3438555

Exploring the role of cancer stem cells in radioresistance

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3438555

Cisplatin treatment increases survival and expansion of a highly tumorigenic side-population fraction by upregulating VEGF/Flt1 autocrine signaling

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3438555

A human colon cancer cell capable of initiating tumour growth in immunodeficient mice

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3438555

Identification and expansion of human colon-cancer-initiating cells

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3438555

Glioma stem cells promote radioresistance by preferential activation of the DNA damage response

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3438555

Chemotherapy with preoperative radiotherapy in rectal cancer

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3438555

Dual antitumor effects of 5-fluorouracil on the cell cycle in colorectal carcinoma cells: a novel target mechanism concept for pharmacokinetic modulating chemotherapy.

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3438555

Quantitative real-time reverse transcription-PCR assay for cyclin D1 expression: utility in the diagnosis of mantle cell lymphoma.

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3438555

Immunohistochemical detection of CD133 expression in colorectal cancer: a clinicopathological study.

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3438555

CD133+CD44+ population efficiently enriches colon cancer initiating cells

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3438555

Stem cell marker CD133 affects clinical outcome in glioma patients.

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3438555

The prognostic role of a gene signature from tumorigenic breast-cancer cells.

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3438555

CD44 is of Functional Importance for Colorectal Cancer Stem Cells

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3438555

Association between pathologic response in metastatic lymph nodes after preoperative chemoradiotherapy and risk of distant metastases in rectal cancer: An analysis of outcomes in a randomized trial

5 December 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22969903

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Pathological features of rectal cancer after preoperative radiochemotherapy

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22969903

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

TNM Classification of Malignant Tumors, fifth edition (1997). Union Internationale Contre le Cancer and the American Joint Committee on Cancer

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22969903

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.3892/ETM.2011.438

1 reference

12 August 2017

1 reference

12 August 2017

PubMed publication ID

22969903

1 reference